205 related articles for article (PubMed ID: 23907461)
1. Selective GPER activation decreases proliferation and activates apoptosis in tumor Leydig cells.
Chimento A; Casaburi I; Bartucci M; Patrizii M; Dattilo R; Avena P; Andò S; Pezzi V; Sirianni R
Cell Death Dis; 2013 Aug; 4(8):e747. PubMed ID: 23907461
[TBL] [Abstract][Full Text] [Related]
2. GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo.
Chimento A; Sirianni R; Casaburi I; Zolea F; Rizza P; Avena P; Malivindi R; De Luca A; Campana C; Martire E; Domanico F; Fallo F; Carpinelli G; Cerquetti L; Amendola D; Stigliano A; Pezzi V
Oncotarget; 2015 Aug; 6(22):19190-203. PubMed ID: 26131713
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Leydig tumor growth by farnesoid X receptor activation: the in vitro and in vivo basis for a novel therapeutic strategy.
Catalano S; Panza S; Malivindi R; Giordano C; Barone I; Bossi G; Lanzino M; Sirianni R; Mauro L; Sisci D; Bonofiglio D; Andò S
Int J Cancer; 2013 May; 132(10):2237-47. PubMed ID: 23124354
[TBL] [Abstract][Full Text] [Related]
4. G protein-coupled estrogen receptor-1 agonist induces chemotherapeutic effect via ER stress signaling in gastric cancer.
Lee SJ; Kim TW; Park GL; Hwang YS; Cho HJ; Kim JT; Lee HG
BMB Rep; 2019 Nov; 52(11):647-652. PubMed ID: 31234952
[TBL] [Abstract][Full Text] [Related]
5. 17β-Estradiol activates GPER- and ESR1-dependent pathways inducing apoptosis in GC-2 cells, a mouse spermatocyte-derived cell line.
Chimento A; Sirianni R; Casaburi I; Ruggiero C; Maggiolini M; Andò S; Pezzi V
Mol Cell Endocrinol; 2012 May; 355(1):49-59. PubMed ID: 22306083
[TBL] [Abstract][Full Text] [Related]
6. SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer.
Santolla MF; Avino S; Pellegrino M; De Francesco EM; De Marco P; Lappano R; Vivacqua A; Cirillo F; Rigiracciolo DC; Scarpelli A; Abonante S; Maggiolini M
Cell Death Dis; 2015 Jul; 6(7):e1834. PubMed ID: 26225773
[TBL] [Abstract][Full Text] [Related]
7. G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1.
Liu C; Liao Y; Fan S; Tang H; Jiang Z; Zhou B; Xiong J; Zhou S; Zou M; Wang J
Med Oncol; 2015 Apr; 32(4):104. PubMed ID: 25744245
[TBL] [Abstract][Full Text] [Related]
8. MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells.
Lappano R; Santolla MF; Pupo M; Sinicropi MS; Caruso A; Rosano C; Maggiolini M
Breast Cancer Res; 2012 Jan; 14(1):R12. PubMed ID: 22251451
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor-I, regulating aromatase expression through steroidogenic factor 1, supports estrogen-dependent tumor Leydig cell proliferation.
Sirianni R; Chimento A; Malivindi R; Mazzitelli I; Andò S; Pezzi V
Cancer Res; 2007 Sep; 67(17):8368-77. PubMed ID: 17804753
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of estradiol-induced insulin secretion by the G protein-coupled estrogen receptor GPR30/GPER in pancreatic beta-cells.
Sharma G; Prossnitz ER
Endocrinology; 2011 Aug; 152(8):3030-9. PubMed ID: 21673097
[TBL] [Abstract][Full Text] [Related]
11. The activation of the G protein-coupled estrogen receptor (GPER) inhibits the proliferation of mouse melanoma K1735-M2 cells.
Ribeiro MPC; Santos AE; Custódio JBA
Chem Biol Interact; 2017 Nov; 277():176-184. PubMed ID: 28947257
[TBL] [Abstract][Full Text] [Related]
12. Nandrolone and stanozolol induce Leydig cell tumor proliferation through an estrogen-dependent mechanism involving IGF-I system.
Chimento A; Sirianni R; Zolea F; De Luca A; Lanzino M; Catalano S; Andò S; Pezzi V
J Cell Physiol; 2012 May; 227(5):2079-88. PubMed ID: 21769864
[TBL] [Abstract][Full Text] [Related]
13. Expression and signaling of G protein-coupled estrogen receptor 1 (GPER) in rat sertoli cells.
Lucas TF; Royer C; Siu ER; Lazari MF; Porto CS
Biol Reprod; 2010 Aug; 83(2):307-17. PubMed ID: 20445128
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancer.
Liu Q; Chen Z; Jiang G; Zhou Y; Yang X; Huang H; Liu H; Du J; Wang H
Mol Cancer; 2017 May; 16(1):87. PubMed ID: 28476123
[TBL] [Abstract][Full Text] [Related]
15. The meaning of non-classical estrogen receptors and peroxisome proliferator-activated receptor for boar Leydig cell of immature testis.
Kotula-Balak M; Duliban M; Pawlicki P; Tuz R; Bilinska B; Płachno BJ; Arent ZJ; Krakowska I; Tarasiuk K
Acta Histochem; 2020 Apr; 122(3):151526. PubMed ID: 32094002
[TBL] [Abstract][Full Text] [Related]
16. Activation of GPER-1 estradiol receptor downregulates production of testosterone in isolated rat Leydig cells and adult human testis.
Vaucher L; Funaro MG; Mehta A; Mielnik A; Bolyakov A; Prossnitz ER; Schlegel PN; Paduch DA
PLoS One; 2014; 9(4):e92425. PubMed ID: 24736568
[TBL] [Abstract][Full Text] [Related]
17. Activation of novel estrogen receptor GPER results in inhibition of cardiocyte apoptosis and cardioprotection.
Li WL; Xiang W; Ping Y
Mol Med Rep; 2015 Aug; 12(2):2425-30. PubMed ID: 25936661
[TBL] [Abstract][Full Text] [Related]
18. Activation of G protein coupled estrogen receptor prevents chemotherapy-induced intestinal mucositis by inhibiting the DNA damage in crypt cell in an extracellular signal-regulated kinase 1- and 2- dependent manner.
Chen G; Zeng H; Li X; Liu J; Li Z; Xu R; Ma Y; Liu C; Xue B
Cell Death Dis; 2021 Oct; 12(11):1034. PubMed ID: 34718327
[TBL] [Abstract][Full Text] [Related]
19. GPER mediates activation of HIF1α/VEGF signaling by estrogens.
De Francesco EM; Pellegrino M; Santolla MF; Lappano R; Ricchio E; Abonante S; Maggiolini M
Cancer Res; 2014 Aug; 74(15):4053-64. PubMed ID: 24894716
[TBL] [Abstract][Full Text] [Related]
20. A novel estrogen receptor GPER mediates proliferation induced by 17β-estradiol and selective GPER agonist G-1 in estrogen receptor α (ERα)-negative ovarian cancer cells.
Liu H; Yan Y; Wen H; Jiang X; Cao X; Zhang G; Liu G
Cell Biol Int; 2014 May; 38(5):631-8. PubMed ID: 24446390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
